Blueprint Medicines Corp
Blueprint Medicines Corp (BPMC) is known on NASDAQ, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerBPMC
- ExchangeNASDAQ
- CurrencyUSD
- Financial periodQ1 2025
- RevenueUSD 149.41M
- Net incomeUSD 496.00K
- Free cash flow-USD 56.31M
- Gross margin98.1%